Filing Details
- Accession Number:
- 0001104659-24-129009
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-12-16 17:37:54
- Reporting Period:
- 2024-12-12
- Accepted Time:
- 2024-12-16 17:37:54
- Original Submission Date:
- 2024-12-16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806384 | Charles Marlio Mosseri | 27 Ripplevale Grove London N1 1HS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-12 | 32,121 | $4.64 | 2,627,121 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-13 | 17,000 | $4.70 | 2,644,121 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions.
Billionaire Hedge Funds
